Abstract
Many studies have examined the association of isoflavone intake with type 2 diabetes (T2D), and produced inconsistent results. Few studies, however, explored the association using objective biomarkers (particular for daidzein metabolite-equol) of isoflavones. We aimed to explore the association of urinary equol, daidzein and genistein concentrations with T2D and examine the mediating roles of high-sensitivity C-reactive protein (hsCRP) and retinol binding protein 4 (RBP4).
Funding Information
  • National Natural Science Foundation of China (81472965, 81502798)
  • Natural Science Foundation of Guangdong Province (2015A030310399)
  • The 5010 Program for Clinical Researches of the Sun Yat-sen University (2007032)

This publication has 49 references indexed in Scilit: